JAMP-NYSTATIN ORAL SUSPENSION USP
JAMP-NYSTATIN ORAL SUSPENSION USP
Approved
DIN Number
02433443
Drug Class
Human
Market Date
Jan 9, 2015
Company
HC
Jamp Pharma Corporation
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02433443
AIG Number0105858002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A07AA02 NYSTATIN
Product Specifications
Dosage FormSuspension
Route of AdministrationOral
AHFS Classification08:14.28
Health Canada Classification
ACTIVE INGREDIENTS (1)
NYSTATINActive
Strength: 100000 UNIT / ML
Monograph: NYSTATIN